Pricing Log in Create free account
Friday 6 November 2026 Export BLLN’s income statement to Excel — free account

BillionToOne, Inc.

BLLN Healthcare Diagnostics & Research

BillionToOne, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $305.1 million, up 100.0% from fiscal 2024.

Revenue
+47.2%
EPS
+164.3%
Free cash flow
+9.25%
Total debt
+60.6%

Quarter to September 2026, against a year earlier

111.96 1.93 −1.69%
Market cap
$5.3B
P/E
88.7×
Fwd P/E
146×
Dividend yield
—
F-score
n/a
Altman Z
6.04
Beneish M
−2.03
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

BillionToOne, Inc. (BLLN) Book value per share

Alert me on Book value per share

BillionToOne, Inc.'s book value per share at the end of fiscal 2025 was 30.2×, compared with −25.0× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 0.0×. BillionToOne, Inc. ranks 40th of 49 Diagnostics & Research companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 30.2× —
FY2024 −25.0× —
FY2023 0.0× —

Quarterly newest first

Period Book value per share Change
Sep 2026 0.0× —
Jun 2026 11.6× 5.09%
Mar 2026 11.0× (63.60%)
Dec 2025 30.2× —
6 more quarters

Book value per share against peers

Company Book value per share
GRAL GRAIL, Inc. compare 52.5×
RDNT RadNet, Inc. compare 17.9×
VCYT Veracyte, Inc. compare 17.8×
QGEN QIAGEN N.V. compare 16.3×
CDNA CareDx, Inc. compare 9.0×
NEO NeoGenomics, Inc. compare 6.2×
SHC Sotera Health Company compare 2.6×
ADPT Adaptive Biotechnologies Corporation compare 1.1×
BLLN BillionToOne, Inc. 0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on BLLN